Deliver effective treatments for
hard-to-treat and resistant cancers
Who We Are
We are a clinical-stage oncology company focused on identifying innovative technologies and advancing truly breakthrough medicines for the treatment of cancer.
Led by an experienced team in translational science and drug development, we acquire licenses for high potential development candidates, we invest in partners with transformative technology platforms, and we build our own internal programs.
Our Company (Onward Therapeutics, Inc.) is headquartered in Taipei, Taiwan, and has a subsidiary (Onward Therapeutics SA) in Lausanne, Switzerland, and two sub-subsidiaries (Onward Therapeutics France including an R&D laboratory, and Emercell) in Paris and Montpellier, France.
Our Pipeline
Onward Therapeutic’s multi-modality approaches are designed to overcome resistance and broaden patient access to innovative therapies
We aim to have three clinical programs by 2029, with the opportunity for licensing-out after achieving clinical Proof-of Concept (PoC) or reaching the most value creating inflection point.
Who We Are
We are a clinical-stage oncology company focused on identifying innovative technologies and advancing truly breakthrough medicines for the treatment of cancer.
Led by an experienced team in translational science and drug development, we acquire licenses for high potential development candidates, we invest in partners with transformative technology platforms, and we build our own internal programs.
Our Company (Onward Therapeutics, Inc.) is headquartered in Taipei, Taiwan, and has a subsidiary (Onward Therapeutics SA) in Lausanne, Switzerland, and two sub-subsidiaries (Onward Therapeutics France including an R&D laboratory, and Emercell) in Paris and Montpellier, France.
Our Pipeline
Onward Therapeutic’s multi-modality approaches are designed to overcome resistance and broaden patient access to innovative therapies
We aim to have three clinical programs by 2029, with the opportunity for licensing-out after achieving clinical Proof-of Concept (PoC) or reaching the most value creating inflection point.
Our Team
Our Team
Our Team
We are a team of dedicated professionals, united by a shared passion for science and innovation. The majority of our members have strong scientific backgrounds and bring extensive experience across a wide range of disciplines. With various nationalities represented, we embrace diversity as a driver of creativity and fresh perspectives.
Our team operates across three vibrant hubs in healthcare - Taipei, Lausanne, and Paris - allowing us to combine global expertise with local insights. This international presence fosters collaboration, agility, and a truly global mindset, enabling us to tackle challenges with both scientific rigor and cultural openness.
Together, we are committed to advancing our mission with excellence, curiosity, and impact.
Partnerships
News & Events
Nov 11, 2025
Swipe down to read more news
Oct 28, 2025
Swipe down to read more news
Jan 24, 2024
Swipe down to read more news
Jul 24, 2023
Swipe down to read more news
Apr 10, 2023
Swipe down to read more news
Sep 23, 2022
Swipe down to read more news
Jun 20, 2022
Swipe down to read more news
Jun 08, 2021
Swipe down to read more news
May 04, 2021
Swipe down to read more news
Feb 17, 2021
Swipe down to read more news
Onward Therapeutics, Inc.
2F, No. 60, Songjiang Road,
Zhongshan District,
Taipei 104090, Taiwan
Onward Therapeutics SA
Biopôle, bâtiment Serine
Route de la Corniche 8
1066 Epalinges, Switzerland
Onward Therapeutics France SAS
77 rue de Vaugirard
75006 Paris, France
contact@onward-therapeutics.com
Content of this website and any communication of Onward Therapeutics has been prepared for general guidance and does not constitute medical advice